Augmenix, Inc. is a privately held Company based in Waltham, MA focused on the development and commercialization of radiation oncology products using its proprietary hydrogel technology. The company was founded by Incept LLC in 2008 and is funded by several leading venture capital groups.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/24/14 | $10,800,000 | Series D |
Catalyst Health Ventures Excelestar Ventures Sparta Group | undisclosed |
| 07/14/16 | $6,000,000 | Series E |
Catalyst Health Ventures Excelestar Ventures Sparta Group | undisclosed |
